---
schema_version: "secwatch.filing_event.v1"
accession: "0000070318-25-000031"
form_type: "8-K"
ticker: "THC"
cik: "0000070318"
company_name: "TENET HEALTHCARE CORP"
filed_at: "2025-07-22T23:59:59+00:00"
generated_at: "2026-05-18T04:42:15.781865+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.85
calibrated_materiality_score: 0.85
confidence: "high"
source: SEC EDGAR
---

# Tenet Q2 adjusted EPS $4.02 (+74% YoY); raises FY 2025 EBITDA outlook to $4.40-$4.54B

## Summary
- Q2 2025 net income $288M, $3.14 diluted EPS; adjusted diluted EPS $4.02 vs $2.31 in Q2 2024.
- Consolidated Adj. EBITDA $1.121B (+18.6% YoY); margin 21.3%. Ambulatory Care Adj. EBITDA $498M (+11.4%).
- Board authorized $1.5B increase to share repurchase program, leaving $1.781B remaining as of July 22.
- FY 2025 Adj. EBITDA outlook raised to $4.40-$4.54B (midpoint +$395M vs prior). Free cash flow guide $2.025-$2.275B.
- H1 2025 free cash flow $1.385B vs $948M in H1 2024; net debt/Adj. EBITDA 2.45x.

## SEC filing metadata
- accession: 0000070318-25-000031
- form_type: 8-K
- ticker: THC
- cik: 0000070318
- company_name: TENET HEALTHCARE CORP
- filed_at: 2025-07-22T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.85
- calibrated_materiality_score: 0.85
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/70318/000007031825000031/0000070318-25-000031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/70318/000007031825000031/thc-20250722.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000070318-25-000031
- JSON: https://secwatch.observer/filing/0000070318-25-000031.json
- Plain text: https://secwatch.observer/filing/0000070318-25-000031.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.